Figure S1. Time course of the degrada1on of ortho-quinone products from catecholamine metabolites at pH 5.3. (A) DOPE (1); (B) DOPEG (2); (C) DOPAC (3); (D) DOMA. Each experiment was performed twice with similar results.
. HPLC following the degrada1on of ortho-quinone products from catecholamine metabolites at pH 5.3. (A,B) DOPE (1); (C,D) DOPEG (2); (E,F) DOPAC (3); (G,H) DOMA. For A, C, E and G, the oxida1on was stopped by the addi1on of NaBH4; For B, D, F and H, the oxida1on was stopped by the addi1on of ascorbic acid. For the sake of clarity, the yields of DHBAld (7) were mul1plied by a factor of 5 in (F). (2) in comparison with those of DOPEG and DHBAld (7). The spectrum of 6-hydroxydopamine was taken with the UV-VIS spectrophotometer, while the others were obtained from HPLC chromatograms analyzed for the wavelength indicated. Maximal absorbance values were normalized to 1. Figure S4 . HPLC chromatograms of (A) 2-oxo-DOPE (5) and (B) DOPEG (2) obtained after the NaBH4 reduc1on of 2-oxo-DOPE. The same molar quan11es were injected for A and B. Figure S5 . 1 H-NMR spectrum of 2-oxo-DOPE (5). X is a peak derived from impurity. Figure S6 . ESI(+)/MS spectrum of 2-oxo-DOPE (5). X is a peak derived from impurity.
